<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3241">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04487639</url>
  </required_header>
  <id_info>
    <org_study_id>RNI 2020 BRUGNON</org_study_id>
    <secondary_id>2020-A01409-30</secondary_id>
    <nct_id>NCT04487639</nct_id>
  </id_info>
  <brief_title>Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?</brief_title>
  <acronym>FERTICOVID</acronym>
  <official_title>Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients During the COVID-19 Pandemic ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agence de La Biom√©decine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the COVID-19 pandemic, the French Agency of Biomedicine has recommended maintaining
      fertility preservation for patients requiring immediate oncological treatments exhibiting
      gonadotoxic effects. However, no study has examined the presence of SARS-CoV-2 in sperm from
      cancer patients. This study aims therefore to detect the presence of SARS-CoV-2, specifically
      in the seminal fluid and the spermatozoa fractions of cancer patient semen. The investigators
      will determine if the virus presence in sperm is associated with its presence in the nasal
      swabs, COVID symptoms, specific serological profiles and particular oncological
      pathologies/treatments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To perform this, all patient undergoing oncological fertility preservation will be evaluated
      for COVID-19 symptomatology (fever, cough, headache, myalgia, diarrhea, anosmia,
      pharyngodynia). In addition, a nasopharyngeal swab for SARS-CoV-2 research by RT- qPCR will
      be performed on the day of semen collection. On the same day, serological tests will be
      carried out, and 30 to 50 days after, according to HAS specifications with methods validated
      by the National Reference Center. Seminal fluid and spermatozoa will be separated by density
      gradient centrifugation for a posteriori molecular analysis of SARS-CoV-2 presence.

      Will thus be measured, within the same ejaculate, the concordance between the presence of
      SARS-CoV-2 in the seminal fluid and in the sperm cells fraction.

      The investigators will also determine if the virus presence in the sperm is related with :

        -  (i) the presence of SARS-CoV-2 in the nasal swab;

        -  (ii) patient symptomatology;

        -  (iii) a specific serological profile;

        -  (iv) a particular oncological pathology and / or treatment. The investigators may also
           find out if the presence of the SARS-CoV-2 in semen affects sperm quality.

      This study will be the first one examining the presence of SARS-CoV-2 in semen from cancer
      patients. This will guarantee the safety of fertility preservation procedures during the
      COVID-19 pandemic.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of SARS-CoV-2 in sperm during fertility preservation procedures by RT-qPCR</measure>
    <time_frame>Semen collection day (Day0)</time_frame>
    <description>Seminal fluid and spermatozoa will be separated by density gradient centrifugation, and SARS-CoV-2 will be detected by RT-qPCR in the both fractions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To correlate the presence of SARS-CoV-2 in the seminal fluid and the spermatozoa fractions of the same ejaculate</measure>
    <time_frame>Semen collection day (Day0)</time_frame>
    <description>We will compare SARS-CoV-2 RT-PCR results of seminal fluid and the spermatozoa fractions of the same ejaculate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the presence of this virus in sperm is associated with its presence in nasal swabs</measure>
    <time_frame>Semen collection day (Day0)</time_frame>
    <description>we will correlate the SARS-CoV-2 detection (using RT- qPCR) in nasopharyngeal swab, seminal fluid and spermatozoa fractions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the presence of this virus in sperm is associated with COVID symptoms</measure>
    <time_frame>Semen collection day (Day0)</time_frame>
    <description>Any patient undergoing oncological fertility preservation will be evaluated for COVID-19 symptomatology (fever, cough, headache, myalgia, diarrhea, anosmia, pharyngodynia). We will correlate the SARS-CoV-2 detection in seminal fluid and spermatozoa fractions with COVID symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the presence of this virus in sperm is associated with specific serological profiles</measure>
    <time_frame>Semen collection day (Day0) and 30 to 50 days after (Day 30 to 50)</time_frame>
    <description>Serological tests (Sars-CoV2) will be carried out. We will correlate the SARS-CoV-2 detection in seminal fluid and spermatozoa fractions with specific COVID serological profiles</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the presence of this virus in sperm is associated with particular oncological pathologies/treatments</measure>
    <time_frame>Semen collection day (Day0)</time_frame>
    <description>We will correlate the SARS-CoV-2 detection in seminal fluid and spermatozoa fractions with patient's oncological pathologies and treatments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the presence of this virus in sperm could impair its quality</measure>
    <time_frame>Semen collection day (Day0)</time_frame>
    <description>Before semen density gradient centrifugation and cryopreservation, standards sperm analysis will be performed according to the WHO guideline (2020). We will correlate the SARS-CoV-2 detection in seminal fluid and spermatozoa fractions with standards sperm parameters</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Sperm Preservation in Oncological Patients</condition>
  <condition>Fertility</condition>
  <condition>Cryopreservation</condition>
  <arm_group>
    <arm_group_label>Cohort : patients needing oncofertility preservation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics</intervention_name>
    <description>a nasopharyngeal swab for SARS-CoV-2 research by RT- qPCR will be performed on the day of semen collection. On the same day, serological tests will be carried out, and 30 to 50 days after, according to HAS specifications with methods validated by the National Reference Center</description>
    <arm_group_label>Cohort : patients needing oncofertility preservation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man above 18 years of age, of reproductive age, needing oncofertility preservation
             through spermatozoa cryopreservation prior to a putative gonadotoxic treatment during
             the COVID-19 pandemic.

          -  Symptomatic and asymptomatic COVID-19 patients. A patient is considered as symptomatic
             if he presents one or several of the following clinical signs: fever, cough,
             cephalalgia, myalgia, diarrhea, anosmia, pharyngodynia.

          -  A sufficient number of remaining spermatozoa straws to perform at least six ART
             attempts

        Exclusion Criteria:

          -  Azoospermia

          -  Severe Oligo-Astheno-Teratozoospermia (OAT) or Cryptozoospermia

          -  Semen collection failure

          -  Non-emergency fertility preservation or treatment with low gonadotoxic risk
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence BRUGNON, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise LACLAUTRE, Pharm D</last_name>
    <phone>04 73 754 963</phone>
    <phone_ext>33</phone_ext>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-H√¥pitaux de Paris - H√¥pital Jean Verdier - Service de Biologie de la reproduction</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florence EUSTACHE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Florence EUSTACHE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Solmaz SARANDI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Badria BENNANI SMIRES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-H√¥pitaux de Paris - H√¥pital Antoine B√©cl√©re - Service de Biologie de la reproduction et AMP DPI CECOS</name>
      <address>
        <city>Clamart</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nelly FRYDMAN, PharmD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Nelly FRYDMAN, PharmD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier BINOIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne MAYEUR, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>La√´titia HESTERS, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand - Laboratoire de Virologie</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>C√©cile HENQUELL, PharmD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>C√©cile HENQUELL, PharmD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Am√©lie BREBION, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey MIRAND, PharmD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence BRUGNON, MD, PhD</last_name>
      <phone>04 73 750 231</phone>
      <phone_ext>33</phone_ext>
      <email>fbrugnon@chu-clermontferrand.fr</email>
    </contact>
    <contact_backup>
      <last_name>Hanae Pons-Rejraji, PhD</last_name>
      <phone>04 73 75 02 31</phone>
      <phone_ext>33</phone_ext>
      <email>hpons-rejraji@chu-clermontferrand.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Florence BRUGNON, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laure CHAPUT, PD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sol√®ne VORILHON, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon - Laboratoire de Biologie de la Reproduction-CECOS</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia FAUQUE, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Patricia FAUQUE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©line BRUNO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie BARBERET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara KOUIRI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble - Laboratoire d'Aide √† la Procr√©ation CECOS</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvianne HENNEBICQU, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sylvianne HENNEBICQU, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien BESSONAT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte MAUROY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas BOUEILH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Service AMP-CECOS</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandrine GISCARD D'ESTAING, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sandrine GISCARD D'ESTAING, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline LORNAGE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elsa LABRUNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H√¥pital de la Conception - AP-H√¥pitaux de Marseille - Service AMP-CECOS</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine GUILLEMAIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine GUILLEMAIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacqueline SAIAS-MAGNAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole Carole, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy - Laboratoire de biologie de la reproduction - CECOS</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine DILIGENT, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine DILIGENT, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle KOSCINSKI, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline AIMONE VIANNA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-H√¥pitaux de Paris - H√¥pital Tenon - Service de Biologie de la reproduction - CECOS</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rachel LEVY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Rachel LEVY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte DUPONT, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rahaf HAJ HAMID, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-H√¥pitaux de Paris - H√¥pital Cochin - Service d'Histologie-Embryologie-Biologie de la reproduction</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine PATRAT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine PATRAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel DULIOUST, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©line CHALAS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>V√©ronique DROUINEAUD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie BARRAUD-LANGE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diane RIVET-DANON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier intercommunal (CHI) de Poissy Saint Germain en Laye</name>
      <address>
        <city>Poissy</city>
        <zip>78300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florence BOITRELLE, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Florence BOITRELLE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion BENDAYAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Reims - Service de Biologie de la Reproduction - CECOS Champagne-Ardenne de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>B√©atrice DELEPINE, MD</last_name>
    </contact>
    <investigator>
      <last_name>B√©atrice DELEPINE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Sophie CANEPA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©line BOUILLON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen Normandie - Service Biologie de la Reproduction-CECOS</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie RIVES, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nathalie RIVES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aur√©lie RIVES-FERAILLE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre DI PIZIO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fanny JUMEAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg - Service de Biologie de la reproduction</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marius TELETIN, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Marius TELETIN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle LICHTBLAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laetitia LADUREAU-FRITSCH, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C√©cile GREZE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arthur LUTON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse - CECOS Midi-Pyr√©n√©es</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie MOINARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nathalie MOINARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis BUJAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Myriam DAUDIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jessika MOREAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 21, 2020</study_first_submitted>
  <study_first_submitted_qc>July 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fertility preservation</keyword>
  <keyword>Sperm</keyword>
  <keyword>Cancer</keyword>
  <keyword>COVID-19</keyword>
  <keyword>SARS-CoV-2</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

